SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts

Advances in Biological Regulation

Volumn 53, Issue 1, 2013, Pages 28-37

  Elong Edimo, William's ^a   Vanderwinden, Jean Marie ^a   Erneux, Christophe ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874002628     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.jbior.2012.09.003     Document Type: Review

References (61)

1. Backers K., Blero D., Paternotte N., Zhang J., Erneux C. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases. Adv Enzyme Regul 2003, 43:15-28.
2. Blero D., Payrastre B., Schurmans S., Erneux C. Phosphoinositide phosphatases in a network of signalling reactions. Pflugers Arch 2007, 455:31-44.
3. Blero D., Zhang J., Pesesse X., Payrastre B., Dumont J.E., Schurmans S., et al. Phosphatidylinositol 3,4,5-trisphosphate modulation in SHIP2-deficient mouse embryonic fibroblasts. FEBS J 2005, 272:2512-2522.
4. Blind R.D., Suzawa M., Ingraham H.A. Direct modification and activation of a nuclear receptor-PIP2 complex by the inositol lipid kinase IPMK. Sci Signal 2012, 5:ra44.
5. Chalhoub N., Baker S.J. PTEN and the PI3-kinase pathway in cancer. Annu Rev Pathol 2009, 4:127-150.
6. Charlier E., Conde C., Zhang J., Deneubourg L., Di V.E., Rahmouni S., et al. SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity. Leukemia 2010, 24:821-832.
7. Cunningham D.L., Sweet S.M., Cooper H.J., Heath J.K. Differential phosphoproteomics of fibroblast growth factor signaling: identification of Src family kinase-mediated phosphorylation events. J Proteome Res 2010, 9:2317-2328.
8. De Schutter J., Guillabert A., Imbault V., Degraef C., Erneux C., Communi D., et al. SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor. J Biol Chem 2009, 284:36062-36076.
9. Dixon M.J., Gray A., Boisvert F.M., Agacan M., Morrice N.A., Gourlay R., et al. A screen for novel phosphoinositide 3-kinase effector proteins. Mol Cell Proteomics 2011, 10:M110.
10. Dowler S., Currie R.A., Campbell D.G., Deak M., Kular G., Downes C.P., et al. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J 2000, 351:19-31.
11. Drayer A.L., Pesesse X., De Smedt F., Woscholski R., Parker P., Erneux C. Cloning and expression of a human placenta inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase. Biochem Biophys Res Commun 1996, 225:243-249.
12. Dubois E., Jacoby M., Blockmans M., Pernot E., Schiffmann S.N., Foukas L.C., et al. Developmental defects and rescue from glucose intolerance of a catalytically-inactive novel Ship2 mutant mouse. Cell Signal 2012, 24:1971-1980.
13. Dyson J.M., Fedele C.G., Davies E.M., Becanovic J., Mitchell C.A. Phosphoinositide phosphatases: just as important as the kinases. Subcell Biochem 2012, 58:215-279.
14. Dyson J.M., O'Malley C.J., Becanovic J., Munday A.D., Berndt M.C., Coghill I.D., et al. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol 2001, 155:1065-1079.
15. Elong Edimo W., Derua R., Janssens V., Nakamura T., Vanderwinden J.M., Waelkens E., et al. Evidence of SHIP2 S132 phosphorylation, its nuclear localization and stability. Biochem J 2011, 439(3):391-401.
16. Elong Edimo W., Janssens V., Waelkens E., Erneux C. Reversible Ser/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?. Bioessays 2012, 34:634-642.
17. Erneux C., Edimo W.E., Deneubourg L., Pirson I. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P3 level, a positive control of PtdIns(3,4)P2 production, and intrinsic docking properties. J Cell Biochem 2011, 112:2203-2209.
18. Gambardella L., Anderson K.E., Nussbaum C., Segonds-Pichon A., Margarido T., Norton L., et al. The GTPase-activating protein ARAP3 regulates chemotaxis and adhesion-dependent processes in neutrophils. Blood 2011, 118:1087-1098.
19. Giuriato S., Blero D., Robaye B., Bruyns C., Payrastre B., Erneux C. SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line. Biochem Biophys Res Commun 2002, 296:106-110.
20. Habib T., Hejna J.A., Moses R.E., Decker S.J. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein. J Biol Chem 1998, 273:18605-18609.
21. Hamilton M.J., Ho V.W., Kuroda E., Ruschmann J., Antignano F., Lam V., et al. Role of SHIP in cancer. Exp Hematol 2011, 39:2-13.
22. Hasegawa J., Tokuda E., Tenno T., Tsujita K., Sawai H., Hiroaki H., et al. SH3YL1 regulates dorsal ruffle formation by a novel phosphoinositide-binding domain. J Cell Biol 2011, 193:901-916.
23. Jurynec M.J., Grunwald D.J. SHIP2, a factor associated with diet-induced obesity and insulin sensitivity, attenuates FGF signaling in vivo. Dis Model Mech 2010, 3:733-742.
24. Kaneko K., Ueki K., Takahashi N., Hashimoto S., Okamoto M., Awazawa M., et al. Class IA phosphatidylinositol 3-kinase in pancreatic beta cells controls insulin secretion by multiple mechanisms. Cell Metab 2010, 12:619-632.
25. Kato K., Yazawa T., Taki K., Mori K., Wang S., Nishioka T., et al. The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration. Mol Biol Cell 2012, 23:2593-2604.
26. Krugmann S., Andrews S., Stephens L., Hawkins P.T. ARAP3 is essential for formation of lamellipodia after growth factor stimulation. J Cell Sci 2006, 119:425-432.
27. Kuo J.C., Han X., Hsiao C.T., Yates J.R., Waterman C.M. Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for beta-Pix in negative regulation of focal adhesion maturation. Nat Cell Biol 2011, 13:383-393.
28. Li W., Laishram R.S., Ji Z., Barlow C.A., Tian B., Anderson R.A. Star-PAP control of BIK expression and apoptosis is regulated by nuclear PIPKIalpha and PKCdelta signaling. Mol Cell 2012, 45:25-37.
29. Martelli A.M., Ognibene A., Buontempo F., Fini M., Bressanin D., Goto K., et al. Nuclear phosphoinositides and their roles in cell biology and disease. Crit Rev Biochem Mol Biol 2011, 46:436-457.
30. McNulty S., Powell K., Erneux C., Kalman D. The host phosphoinositide 5-phosphatase SHIP2 regulates dissemination of vaccinia virus. J Virol 2011, 85:7402-7410.
31. Mellman D.L., Gonzales M.L., Song C., Barlow C.A., Wang P., Kendziorski C., et al. A PtdIns4,5P2-regulated nuclear poly(A) polymerase controls expression of select mRNAs. Nature 2008, 451:1013-1017.
32. Ming-Lum A., Shojania S., So E., McCarrell E., Shaw E., Vu D., et al. A pleckstrin homology-related domain in SHIP1 mediates membrane localization during Fcgamma receptor-induced phagocytosis. FASEB J 2012, 26(8):3163-3177. 3163-3167.
33. Mortier E., Wuytens G., Leenaerts I., Hannes F., Heung M.Y., Degeest G., et al. Nuclear speckles and nucleoli targeting by PIP2-PDZ domain interactions. EMBO J 2005, 24:2556-2565.
34. Muraille E., Bruhns P., Pesesse X., Daeron M., Erneux C. The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling. Immunol Lett 2000, 72:7-15.
35. Muraille E., Dassesse D., Vanderwinden J.M., Cremer H., Rogister B., Erneux C., et al. The SH2 domain-containing 5-phosphatase SHIP2 is expressed in the germinal layers of embryo and adult mouse brain: increased expression in N-CAM-deficient mice. Neuroscience 2001, 105:1019-1030.
36. Muraille E., Pesesse X., Kuntz C., Erneux C. Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Biochem J 1999, 342(Pt 3):697-705.
37. Nakatsu F., Perera R.M., Lucast L., Zoncu R., Domin J., Gertler F.B., et al. The inositol 5-phosphatase SHIP2 regulates endocytic clathrin-coated pit dynamics. J Cell Biol 2010, 190(3):307-315.
38. Ono M., Bolland S., Tempst P., Ravetch J.V. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 1996, 383:263-266.
39. Ooms L.M., Horan K.A., Rahman P., Seaton G., Gurung R., Kethesparan D.S., et al. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. Biochem J 2009, 419:29-49.
40. Paternotte N., Zhang J., Vandenbroere I., Backers K., Blero D., Kioka N., et al. SHIP2 interaction with the cytoskeletal protein Vinexin. FEBS J 2005, 272:6052-6066.
41. Pesesse X., Dewaste V., De Smedt F., Laffargue M., Giuriato S., Moreau C., et al. The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells. J Biol Chem 2001, 276:28348-28355.
42. Pirruccello M., De Camilli P. Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL. Trends Biochem Sci 2012, 37(4):134-143.
43. Prasad N., Topping R.S., Decker S.J. SH2-containing inositol 5'-phosphatase SHIP2 associates with the p130(Cas) adapter protein and regulates cellular adhesion and spreading. Mol Cell Biol 2001, 21:1416-1428.
44. Raaijmakers J.H., Deneubourg L., Rehmann H., de K.J., Zhang Z., Krugmann S., et al. The PI3K effector Arap3 interacts with the PI(3,4,5)P3 phosphatase SHIP2 in a SAM domain-dependent manner. Cell Signal 2007, 19:1249-1257.
45. Saarikangas J., Zhao H., Lappalainen P. Regulation of the actin cytoskeleton-plasma membrane interplay by phosphoinositides. Physiol Rev 2010, 90:259-289.
46. Sleeman M.W., Wortley K.E., Lai K.M., Gowen L.C., Kintner J., Kline W.O., et al. Absence of the lipid phosphatase SHIP2 confers resistance to diary obesity. Nat Med 2005, 11:199-205.
47. Song M.S., Salmena L., Pandolfi P.P. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 2012, 283-296.
48. Suwa A., Kurama T., Shimokawa T. SHIP2 and its involvement in various diseases. Expert Opin Ther Targets 2010, 14:727-737.
49. Takabayashi T., Xie M.J., Takeuchi S., Kawasaki M., Yagi H., Okamoto M., et al. LL5beta directs the translocation of filamin A and SHIP2 to sites of phosphatidylinositol 3,4,5-triphosphate (PtdIns(3,4,5)P3) accumulation, and PtdIns(3,4,5)P3 localization is mutually modified by co-recruited SHIP2. J Biol Chem 2010, 285:16155-16165.
50. Taylor V., Wong M., Brandts C., Reilly L., Dean N.M., Cowsert L.M., et al. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol Cell Biol 2000, 20:6860-6871.
51. Vandenbroere I., Paternotte N., Dumont J.E., Erneux C., Pirson I. The c-Cbl-associated protein and c-Cbl are two new partners of the SH2-containing inositol polyphosphate 5-phosphatase SHIP2. Biochem Biophys Res Commun 2003, 300:494-500.
52. Venkatareddy M., Cook L., Abuarquob K., Verma R., Garg P. Nephrin regulates lamellipodia formation by assembling a protein complex that includes Ship2, filamin and lamellipodin. PLoS One 2011, 6:e28710.
53. Viiri K., Maki M., Lohi O. Phosphoinositides as regulators of protein-chromatin interactions. Sci Signal 2012, 5:e19.
54. Wang Y.J., Keogh R.J., Hunter M.G., Mitchell C.A., Frey R.S., Javaid K., et al. SHIP2 is recruited to the cell membrane upon macrophage colony-stimulating factor (M-CSF) stimulation and regulates M-CSF-induced signaling. J Immunol 2004, 173:6820-6830.
55. Wisniewski D., Strife A., Swendeman S., Erdjument-Bromage H., Geromanos S., Kavanaugh W.M., et al. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood 1999, 93:2707-2720.
56. Wullschleger S., Wasserman D.H., Gray A., Sakamoto K., Alessi D.R. Role of TAPP1 and TAPP2 adaptors binding to PtdIns(3,4)P2 in regulating insulin sensitivity defined by knock-in analysis. Biochem J 2011, 434:265-274.
57. Xie J., Onnockx S., Vandenbroere I., Degraef C., Erneux C., Pirson I. The docking properties of SHIP2 influence both JIP1 tyrosine phosphorylation and JNK activity. Cell Signal 2008, 20:1432-1441.
58. Xie J., Vandenbroere I., Pirson I. SHIP2 associates with intersectin and recruits it to the plasma membrane in response to EGF. FEBS Lett 2008, 582:3011-3017.
59. Zhang J., Liu Z., Rasschaert J., Blero D., Deneubourg L., Schurmans S., et al. SHIP2 controls PtdIns(3,4,5)P(3) levels and PKB activity in response to oxidative stress. Cell Signal 2007, 19:2194-2200.
60. Zhuang G., Hunter S., Hwang Y., Chen J. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via PI3 kinase-dependent Rac1 activation. J Biol Chem 2006, 282:2683-2694.
61. Zwaenepoel K., Goris J., Erneux C., Parker P.J., Janssens V. Protein phosphatase 2A PR130/B'alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling. FASEB J 2010, 24:538-547.